Evidence map›Paper›PMID 26730353›Full record

ArticleJournal of pathology informatics2015

International telepathology consultation: Three years of experience between the University of Pittsburgh Medical Center and KingMed Diagnostics in China.

Chengquan Zhao, Tao Wu, Xiangdong Ding, Anil V Parwani, Hualin Chen, Jeffrey McHugh, Anthony Piccoli, Qinling Xie, Gonzalo Romero Lauro, Xiaodong Feng and 6 more

Abstract read
In one paragraph

Article in Journal of pathology informatics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Artificial intelligence (AI) and big data in cancer and precision oncology.Computational and structural biotechnology journal · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. The Empirical Foundations of Telepathology: Evidence of Feasibility and Intermediate Effects.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2017
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Chengquan ZhaoDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Tao WuDepartment of Pathology, KingMed Diagnostics, Guangzhou, Guangdong, China.
Xiangdong DingDepartment of Pathology, KingMed Diagnostics, Guangzhou, Guangdong, China.
Anil V ParwaniDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Hualin ChenDepartment of Pathology, KingMed Diagnostics, Guangzhou, Guangdong, China.
Jeffrey McHughDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Anthony PiccoliDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Qinling XieDepartment of Pathology, KingMed Diagnostics, Guangzhou, Guangdong, China.
Gonzalo Romero LauroDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Xiaodong FengDepartment of Pathology, KingMed Diagnostics, Guangzhou, Guangdong, China.
Douglas J HartmanDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Raja R SeethalaDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Shangwei WuDepartment of Pathology, KingMed Diagnostics, Guangzhou, Guangdong, China.
Samuel YousemDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Yaoming LiangDepartment of Pathology, KingMed Diagnostics, Guangzhou, Guangdong, China.
Liron PantanowitzDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTelepathology is increasingly being employed to support diagnostic consultation services. Prior publications have addressed technology aspects for telepathology, whereas this paper will address the clinical telepathology experience of KingMed Diagnostics, the largest independent pathology medical laboratory in China. Beginning in 2012 the University of Pittsburgh Medical Center (UPMC) and KingMed Diagnostics partnered to establish an international telepathology consultation service. MATERIALS AND

methodsThis is a retrospective study that summarizes the telepathology experience and diagnostic consultation results between UPMC and KingMed over a period of 3 years from January 2012 to December 2014.

resultsA total of 1561 cases were submitted for telepathology consultation including 144 cases in 2012, 614 cases in 2013, and 803 in 2014. Most of the cases (61.4%) submitted were referred by pathologists, 36.9% by clinicians, and 1.7% by patients in China. Hematopathology received the most cases (23.7%), followed by bone/soft tissue (21.0%) and gynecologic/breast (20.2%) subspecialties. Average turnaround time (TAT) per case was 5.4 days, which decreased from 6.8 days in 2012 to 5.0 days in 2014. Immunostains were required for most of the cases. For some difficult cases, more than one round of immunostains was needed, which extended the TAT. Among 855 cases (54.7%) where a primary diagnosis or impression was provided by the referring local hospitals in China, the final diagnoses rendered by UPMC pathologists were identical in 25.6% of cases and significantly modified (treatment plan altered) in 50.8% of cases.

conclusionThese results indicate that international telepathology consultation can significantly improve patient care by facilitating access to pathology expertise. The success of this international digital consultation service was dependent on strong commitment and support from leadership, information technology expertise, and dedicated pathologists who understood the language and culture on both sides. Lack of clinical information, missing gross pathology descriptions, and insufficient tissue sections submitted for evaluation were the main reasons for indefinite diagnoses. The overall experience encourages international telepathology practice for second opinions.

Indexed as

Chinadigital pathologyteleconsultationtelepathologywhole slide imaging

Identifiers

PMID26730353
PMCPMC4687159

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.